Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study

Catheterization and Cardiovascular Interventions

Volumn 87, Issue 2, 2016, Pages 332-338

  Ciuca, Cristina ^a   Tarantini, Giuseppe ^b   Latib, Azeem ^c,d   Gasparetto, Valeria ^b   Savini, Carlo ^e   Di Eusanio, Marco ^e   Napodano, Massimo ^b   Maisano, Francesco ^d   Gerosa, Gino ^b   Sticchi, Alessandro ^c,d   Marzocchi, Antonio ^a   Alfieri, Ottavio ^d   Colombo, Antonio ^c,d   Saia, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

aortic stenosis; outcome; transcatheter aortic valve replacement; vascular access

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; AGED; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SEPSIS; SURVIVAL TIME; TRANS SUBCLAVIAN ACCESS; TRANSAPICAL ACCESS; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; CATHETERIZATION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; ITALY; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK FACTOR; SUBCLAVIAN ARTERY; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CATHETERIZATION, PERIPHERAL; CHI-SQUARE DISTRIBUTION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RISK FACTORS; SUBCLAVIAN ARTERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959457329     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26012     Document Type: Article

References (19)

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, Bonis D, Evangelista M, Falk A, Iung V, Lancellotti B, Pierard P, Price L, Schäfers S, Schuler HJ, Stepinska G, Swedberg J, Takkenberg K, Von Oppell J, Windecker UO, Zamorano S, Zembala JLM,. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496.
2. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Belle E, Laskar M;, FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
3. Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D, Ludman MADEBPF,. Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI registry. J Interv Cardiol 2014; 27: 86-95.
4. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB;, PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686 -16 95.
5. van der Boon RM, Marcheix B, Tchetche D, Chieffo A, Van Mieghem NM, Dumonteil N, Vahdat O, Maisano F, Serruys PW, Kappetein AP, Fajadet J, Colombo A, Carrié D, van Domburg RT, de Jaegere PP,. Transapical versus transfemoral aortic valve implantation: A multicenter collaborative study. Ann Thorac Surg 2014; 97: 22-28.
6. Petronio AS, De Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, Poli A, Marzocchi A, Santoro G, Napodano M, Ussia GP, Giannini C, Brambilla N, Colombo A,. 2-year results of CoreValve implantation through the subclavian access: A propensity-matched comparison with the femoral access. J Am Coll Cardiol 2012; 60: 502-507.
7. Petronio AS, De Carlo M, Giannini C, De Caro F, Bortolotti U,. Subclavian TAVI: More than an alternative access route. EuroIntervention 2012; 9(Suppl): S33-S37.
8. Bapat VN, Bruschi G,. Transaortic access is the key to success. EuroIntervention 2013; 9(Suppl): S25-S32.
9. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB,. Valve academic research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145: 6-23.
10. Haussig S, Schuler G, Linke A,. Worldwide TAVI registries: what have we learned? Clin Res Cardiol 2014; 103: 603-612.
11. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH,. Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-analysis of 10,037 published patients. EuroIntervention 2012; 8: 129-138.
12. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochellière R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E,. Long-term outcomes after transcatheter aortic valve implantation: Insights on prognostic factors and valve durability from the canadian multicenter experience. J Am Coll Cardiol 2012; 60: 1864-1875.
13. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ;, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
14. Lemos PA, Saia F, Mariani J Jr, Marrozzini C, Filho AE, Kajita LJ, Ciuca C, Taglieri N, Bordoni B, Moretti C, Palmerini T, Dracoulakis MD, Jatene FB, Kalil-Filho R, Marzocchi A,. Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation. Int J Cardiol 2012; 157: 288-289.
15. Abdel-Wahab M, Zahn R, Gerckens U, Linke A, Sievert H, Schäfer U, Kahlert P, Hambrecht R, Sack S, Hoffmann E, Senges J, Schneider S, Richardt G,; German TAVI Registry Investigators. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: An analysis from the multicenter German TAVI registry. Heart 2014; 100: 1250-1256.
16. Van Mieghem NM, van der Boon RM, Nuis RJ, Schultz C, van Geuns RJ, Serruys PW, Kappetein AP, van Domburg RT, de Jaegere PP,. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2014; 83: E277-E282.
17. Saia F, Latib A, Ciuca C, Gasparetto V, Napodano M, Sticchi A, Anderlucci L, Marrozzini C, Naganuma T, Alfieri O, Facchin M, Hoxha B, Moretti C, Marzocchi A, Colombo A, Tarantini G,. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. Am Heart J 2014; 168: 798-806.
18. Pilgrim T, Stortecky S, Luterbacher F, Windecker S, Wenaweser P,. Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis. J Thromb Thrombolysis 2013; 35: 456-462.
19. Saia F, Marrozzini C, Moretti C, Ciuca C, Taglieri N, Bordoni B, Dall'ara G, Alessi L, Lanzillotti V, Bacchi-Reggiani ML, Branzi A, Marzocchi A,. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention 2011; 7: 723-30.